These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30744452)

  • 41. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT.
    Juraschek SP; Taylor AA; Wright JT; Evans GW; Miller ER; Plante TB; Cushman WC; Gure TR; Haley WE; Moinuddin I; Nord J; Oparil S; Pedley C; Roumie CL; Whittle J; Wiggers A; Finucane C; Anne Kenny R; Appel LJ; Townsend RR;
    Hypertension; 2020 Mar; 75(3):660-667. PubMed ID: 31983312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
    Myers MG; Kaczorowski J; Dolovich L; Tu K; Paterson JM
    Hypertension; 2016 Oct; 68(4):866-72. PubMed ID: 27528062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SPRINT trial: It's not just the blood pressure!
    Berkelmans GF; Visseren FL; Jaspers NE; Spiering W; van der Graaf Y; Dorresteijn JA
    Eur J Prev Cardiol; 2017 Sep; 24(14):1482-1484. PubMed ID: 28749177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial.
    Odden MC; McClure LA; Sawaya BP; White CL; Peralta CA; Field TS; Hart RG; Benavente OR; Pergola PE
    Hypertension; 2016 Jan; 67(1):63-9. PubMed ID: 26553236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease.
    Chang TI; Wei G; Boucher R; Kramer H; Chertow GM; Cheung AK; Greene T; Whelton PK; Beddhu S
    Kidney360; 2020 May; 1(5):368-375. PubMed ID: 35369376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diastolic Blood Pressure and Intensive Blood Pressure Control on Cognitive Outcomes: Insights From the SPRINT MIND Trial.
    Jiang C; Li S; Wang Y; Lai Y; Bai Y; Zhao M; He L; Kong Y; Guo X; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Anderson CS; Ma C
    Hypertension; 2023 Mar; 80(3):580-589. PubMed ID: 36688305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. China Stroke Primary Prevention Trial: Visit-to-Visit Systolic Blood Pressure Variability Is an Independent Predictor of Primary Stroke in Hypertensive Patients.
    Men X; Sun W; Fan F; Zhao M; Huang X; Wang Y; Liu L; Liu R; Sun W; Peng Q; Qin X; Tang G; Li J; Zhang Y; Cai Y; Hou FF; Wang B; Xu X; Cheng X; Sun N; Huang Y; Huo Y
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28288974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Intensive Systolic Blood Pressure Control on All-Cause Hospitalizations.
    Rocco MV; Comeau ME; Marion MC; Freedman BI; Hawfield AT; Langefeld CD;
    Hypertension; 2020 Dec; 76(6):1717-1724. PubMed ID: 33100049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Rocco MV; Sink KM; Lovato LC; Wolfgram DF; Wiegmann TB; Wall BM; Umanath K; Rahbari-Oskoui F; Porter AC; Pisoni R; Lewis CE; Lewis JB; Lash JP; Katz LA; Hawfield AT; Haley WE; Freedman BI; Dwyer JP; Drawz PE; Dobre M; Cheung AK; Campbell RC; Bhatt U; Beddhu S; Kimmel PL; Reboussin DM; Chertow GM;
    Am J Kidney Dis; 2018 Mar; 71(3):352-361. PubMed ID: 29162340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Wang KM; Stedman MR; Chertow GM; Chang TI
    Hypertension; 2020 Dec; 76(6):1725-1733. PubMed ID: 33131314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial.
    Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Catanese L; McClure LA; Benavente OR; Peralta CA
    J Am Heart Assoc; 2019 Feb; 8(3):e010091. PubMed ID: 30686103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
    Widimský J
    Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial.
    Jaeger BC; Bress AP; Bundy JD; Cheung AK; Cushman WC; Drawz PE; Johnson KC; Lewis CE; Oparil S; Rocco MV; Rapp SR; Supiano MA; Whelton PK; Williamson JD; Wright JT; Reboussin DM; Pajewski NM
    JAMA Cardiol; 2022 Nov; 7(11):1138-1146. PubMed ID: 36223105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.
    Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
    Diabetes Care; 2017 Dec; 40(12):1733-1738. PubMed ID: 28947569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Broda G; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Sans S; Olsen MH;
    Hypertension; 2012 Nov; 60(5):1117-23. PubMed ID: 23006731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating Systolic Blood Pressure Intervention Trial Participant Posttrial Survival Using Pooled Epidemiologic Cohort Data.
    Bellows BK; Zhang Y; Zhang Z; Lloyd-Jones DM; Bress AP; King JB; Kolm P; Cushman WC; Johnson KC; Tamariz L; Oelsner EC; Shea S; Newman AB; Ives DG; Couper D; Moran AE; Weintraub WS
    J Am Heart Assoc; 2021 May; 10(10):e020361. PubMed ID: 33955229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
    Dolui S; Detre JA; Gaussoin SA; Herrick JS; Wang DJJ; Tamura MK; Cho ME; Haley WE; Launer LJ; Punzi HA; Rastogi A; Still CH; Weiner DE; Wright JT; Williamson JD; Wright CB; Bryan RN; Bress AP; Pajewski NM; Nasrallah IM
    JAMA Neurol; 2022 Apr; 79(4):380-389. PubMed ID: 35254390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial).
    Johnson KC; Whelton PK; Cushman WC; Cutler JA; Evans GW; Snyder JK; Ambrosius WT; Beddhu S; Cheung AK; Fine LJ; Lewis CE; Rahman M; Reboussin DM; Rocco MV; Oparil S; Wright JT;
    Hypertension; 2018 May; 71(5):848-857. PubMed ID: 29531173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal Systolic Blood Pressure Levels for Primary Prevention of Stroke in General Hypertensive Adults: Findings From the CSPPT (China Stroke Primary Prevention Trial).
    Fan F; Yuan Z; Qin X; Li J; Zhang Y; Li Y; Yu T; Ji M; Ge J; Zheng M; Yang X; Bao H; Cheng X; Gu D; Zhao D; Wang J; Sun N; Chen Y; Wang H; Wang X; Parati G; Hou F; Xu X; Wang X; Zhao G; Huo Y
    Hypertension; 2017 Apr; 69(4):697-704. PubMed ID: 28242714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.